62 related articles for article (PubMed ID: 35322386)
1. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
Bykonya AG; Lavrov AV; Smirnikhina SA
Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
[TBL] [Abstract][Full Text] [Related]
2. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing.
Im SH; Jang M; Park JH; Chung HJ
J Nanobiotechnology; 2024 Apr; 22(1):175. PubMed ID: 38609947
[TBL] [Abstract][Full Text] [Related]
3. Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
Dubey S; Chen Z; Jiang YJ; Talis A; Molotkov A; Ali A; Mintz A; Momen-Heravi F
Theranostics; 2024; 14(7):2777-2793. PubMed ID: 38773978
[TBL] [Abstract][Full Text] [Related]
4. Cationic lipid nanoparticle-mediated delivery of a Cas9/crRNA ribonucleoprotein complex for transgene-free editing of the citrus plant genome.
Mahmoud LM; Dutt M
Plant Cell Rep; 2024 Jun; 43(7):171. PubMed ID: 38874819
[TBL] [Abstract][Full Text] [Related]
5. Efficient genome editing in filamentous fungi via an improved CRISPR-Cas9 ribonucleoprotein method facilitated by chemical reagents.
Zou G; Xiao M; Chai S; Zhu Z; Wang Y; Zhou Z
Microb Biotechnol; 2021 Nov; 14(6):2343-2355. PubMed ID: 32841542
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms.
Farboud B; Jarvis E; Roth TL; Shin J; Corn JE; Marson A; Meyer BJ; Patel NH; Hochstrasser ML
J Vis Exp; 2018 May; (135):. PubMed ID: 29889198
[TBL] [Abstract][Full Text] [Related]
7. Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing.
Mun D; Kang JY; Kim H; Yun N; Joung B
J Control Release; 2024 Jun; 370():798-810. PubMed ID: 38754633
[TBL] [Abstract][Full Text] [Related]
8. A Guanidinobenzol-Rich Polymer Overcoming Cascade Delivery Barriers for CRISPR-Cas9 Genome Editing.
Liang S; Ma N; Li X; Yun K; Meng QF; Ma K; Yue L; Rao L; Chen X; Wang Z
Nano Lett; 2024 Jun; 24(23):6872-6880. PubMed ID: 38683656
[TBL] [Abstract][Full Text] [Related]
9. Near-Infrared Light Activated Formulation for the Spatially Controlled Release of CRISPR-Cas9 Ribonucleoprotein for Brain Gene Editing.
Simões S; Lino M; Barrera A; Rebelo C; Tomatis F; Vilaça A; Breunig C; Neuner A; Peça J; González R; Carvalho A; Stricker S; Ferreira L
Angew Chem Int Ed Engl; 2024 May; 63(21):e202401004. PubMed ID: 38497898
[TBL] [Abstract][Full Text] [Related]
10. Genome Editing in Ferret Airway Epithelia Mediated by CRISPR/Nucleases Delivered with Amphiphilic Shuttle Peptides.
Luo M; Ma J; Cheng X; Wu S; Bartels DJ; Guay D; Engelhardt JF; Liu X
Hum Gene Ther; 2023 Aug; 34(15-16):705-718. PubMed ID: 37335046
[TBL] [Abstract][Full Text] [Related]
11. Engineering self-deliverable ribonucleoproteins for genome editing in the brain.
Chen K; Stahl EC; Kang MH; Xu B; Allen R; Trinidad M; Doudna JA
Nat Commun; 2024 Feb; 15(1):1727. PubMed ID: 38409124
[TBL] [Abstract][Full Text] [Related]
12. CRISPRoff enables spatio-temporal control of CRISPR editing.
Carlson-Stevermer J; Kelso R; Kadina A; Joshi S; Rossi N; Walker J; Stoner R; Maures T
Nat Commun; 2020 Oct; 11(1):5041. PubMed ID: 33028827
[TBL] [Abstract][Full Text] [Related]
13. Analysis of conventional and alternative CRISPR/Cas9 genome editing to enhance a single-base pair knock-in mutation.
Edmondson C; Zhou Q; Liu X
BMC Biotechnol; 2021 Jul; 21(1):45. PubMed ID: 34315458
[TBL] [Abstract][Full Text] [Related]
14. Efficient Genome Editing in Multiple Salmonid Cell Lines Using Ribonucleoprotein Complexes.
Gratacap RL; Jin YH; Mantsopoulou M; Houston RD
Mar Biotechnol (NY); 2020 Oct; 22(5):717-724. PubMed ID: 32946000
[TBL] [Abstract][Full Text] [Related]
15. Efficient Editing of the CXCR4 Locus Using Cas9 Ribonucleoprotein Complexes Stabilized with Polyglutamic Acid.
Golubev DS; Komkov DS; Shepelev MV; Mazurov DV; Kruglova NA
Dokl Biol Sci; 2023 Dec; 513(Suppl 1):S28-S32. PubMed ID: 38190037
[TBL] [Abstract][Full Text] [Related]
16. Visual screening of CRISPR/Cas9 editing efficiency based on micropattern arrays for editing porcine cells.
Peng W; Gao M; Zhu X; Liu X; Yang G; Li S; Liu Y; Bai L; Yang J; Bao J
Biotechnol J; 2024 Apr; 19(4):e2300691. PubMed ID: 38622798
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation.
Sun W; Wang J; Hu Q; Zhou X; Khademhosseini A; Gu Z
Sci Adv; 2020 May; 6(21):eaba2983. PubMed ID: 32490205
[TBL] [Abstract][Full Text] [Related]
18. Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy.
Ho TC; Kim HS; Chen Y; Li Y; LaMere MW; Chen C; Wang H; Gong J; Palumbo CD; Ashton JM; Kim HW; Xu Q; Becker MW; Leong KW
Sci Adv; 2021 May; 7(21):. PubMed ID: 34138728
[TBL] [Abstract][Full Text] [Related]
19. Efficiency, Specificity and Temperature Sensitivity of Cas9 and Cas12a RNPs for DNA-free Genome Editing in Plants.
Banakar R; Schubert M; Kurgan G; Rai KM; Beaudoin SF; Collingwood MA; Vakulskas CA; Wang K; Zhang F
Front Genome Ed; 2021; 3():760820. PubMed ID: 35098208
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas12a ribonucleoprotein-mediated gene editing in the plant pathogenic fungus
Huang J; Cook DE
STAR Protoc; 2022 Mar; 3(1):101072. PubMed ID: 35005648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
